Brief: Aptinyx Reports Second Quarter 2022 Financial Results And Recent Highlights
Aug 4 (Reuters) - Aptinyx Inc APTX.O :
* APTINYX REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND
RECENT
HIGHLIGHTS
* EXPECTS TO REPORT RESULTS FROM PHASE 2B STUDY OF NYX-2925
IN
FIBROMYALGIA IN AUGUST
* EXPECTS ITS CURRENT CASH BALANCE TO FUND READOUTS FROM
EACH OF
PHASE 2 CLINICAL DEVELOPMENT PROGRAMS, SUPPORT ANTICIPATED
OPERATIONS INTO 2024
* QTRLY LOSS PER SHARE $0.26
* Q2 EARNINGS PER SHARE VIEW $-0.28 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBwW5byGa
Further company coverage: APTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptinyx
See all newsBrief: Aptinyx Gets Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
Brief: Aptinyx Inc reports On May 4, Board Deemed It In Best Interests Of Co And Its Stockholders That Co Be Dissolved
Aptinyx Inc reports results for the quarter ended in December - Earnings Summary
Brief: Aptinyx Inc Reports Quarterly Loss Per Share Of $0.18
Aptinyx Inc expected to post a loss of 19 cents a share - Earnings Preview